Key facts
- This page summarizes David M. Stack's Form 4 filing for Pacira BioSciences, Inc. (PCRX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 May 2022, 18:34.
David M. Stack - 28 Apr 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)
- Reporting relationship
- CEO and Chairman, Director
- Issuer ticker
- PCRX
- Reported as of
- 28 Apr 2022
- Net transaction value
- +$243,225
- SEC form
- 4
- Accepted by SEC
- 02 May 2022, 18:34:31 UTC
- Prior SEC filing
- 05 Apr 2022
- Next SEC filing
- 08 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristen Williams, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David M. Stack filed Form 4 for Pacira BioSciences, Inc. (PCRX) on 02 May 2022.
Change
- Previous filing in this sequence was filed on 05 Apr 2022.
- Current net transaction value: +$243,225.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCRX
transaction
Common Stock
Options Exercise
- Transaction value
- $243,225
- Shares
- +22,500
- Change %
- +15%
- Price
- $10.81
- Shares after
- 168,044
- Date
- 28 Apr 2022
- Ownership
- Direct
- Footnotes
- F1
PCRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 97,273
- Date
- 28 Apr 2022
- Ownership
- By Three Colleens Investment, LLC
- Footnotes
- F2
PCRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,596
- Date
- 28 Apr 2022
- Ownership
- By Stack Schroon Mohawk FLP
- Footnotes
- F2
PCRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 315
- Date
- 28 Apr 2022
- Ownership
- LCK Investment LLC
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCRX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -22,500
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,500
- Exercise price
- $10.81
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Footnote F2
Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
Footnote F3
The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.